Global private equity and venture capital news and research

Posts Tagged ‘Bridgepoint’

15 July 2014

Bridgepoint confirms return to fundraising trail, could raise €4bn

london bridge European private equity firm Bridgepoint is officially back in the fundraising market for its fifth flagship vehicle.

14 July 2014

Inflexion gets 2.8x return from Phlexglobal exit to Bridgepoint

exitt Private equity firm Inflexion has made a cash return of 2.8 times from the exit of document management technology specialist Phlexglobal, which was sold to Bridgepoint Development Capital.

7 July 2014

Bridgepoint bags 2.6x return, 35% IRR selling microchip etcher SPTS for $370mp

circuit_board_lrg UK-based private equity firm Bridgepoint has scored a 2.6-times return exiting microchip equipment manufacturer SPTS to Orbotech in a $370m cash deal.

4 July 2014

Bridgepoint’s Infront Sports seeks €155m loan for dividend recap

bolttt Swiss sports marketing company Infront Sports & Media is reportedly looking to secure a further €155m of loans to pay dividend to its private equity backer Bridgepoint.

22 May 2014

Bridgepoint-backed Fat Face cancels London IPO

clothing scarves_sq Private equity-backed clothing retailer fat Face has cancelled its plans to an IPO in London due to unfavorable market conditions.

1 May 2014

Bridgepoint-backed FatFace eyes £110m London IPO

clothing scarves_sq FatFace is preparing for an IPO on the London Stock Exchange, which is expected to value the private equity-backed British clothing chain at £440m.

22 April 2014

Permira acquires chemicals maker CABB from Bridgepoint

german flag 2_sq Permira has bought fine chemicals manufacturer CABB International from fellow European private equity firm Bridgepoint.

17 March 2014

Bridgepoint plans CABB chemicals exit after three years

London-based private equity firm Bridgepoint is reportedly looking to exit German chemicals maker CABB after three years of ownership.

5 March 2014

Bridgepoint seeks up to €4bn for new fund

London taxis Private equity firm Bridgepoint is reportedly planning to raise up to €4bn for its next buyout fund.

26 February 2014

Bridgepoint’s Diaverum exit hopes rise amid interest from trade giant Fresenius

Thrasos Therapeutics kidney - AltAssets Private Equity News The world’s biggest provider of dialysis treatment has admitted it could be interested in Bridgepoint-backed rival Diaverum as the buyout house looks for an exit.

Page 1 of 41234

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014